Clearance of nasal Staphylococcus aureus colonization with triple antibiotic ointment.
Elizabeth M Grossman, Shivani Nanda, Jennifer R S Gordon, Meghan Dubina, Alfred W Rademaker, Dennis P West, Peter A Lio
Index: Journal. of. Drugs in. Dermatology. 11(12) , 1490-2, (2012)
Full Text: HTML
Abstract
The prevalence of Staphylococcus aureus colonization of healthcare workers is reported at 30%, with colonization rates for methicillin-resistant S aureus (MRSA) reported between 2.0% and 8.5% among industrialized nations. The anterior nares are the most frequent colonization site. Mupirocin is the standard of care for nasal S aureus decolonization, with decolonization rates as high as 90%. Staphyloccocal resistance to mupirocin has been described, requiring additional management strategies. In certain situations, triple antibiotic ointment (TAO) may be a suitable alternative for elimination of nasal S aureus colonization.Adult healthcare workers within an academic-centered hospital (n=216) were screened via nasal swab with culture for S aureus colonization. Forty-!ve subjects (20.8%) screened positive for S aureus; of these subjects, 3 (1.4%) were positive for MRSA. Of the 45 subjects with positive cultures, 30 completed 5 days of twice-daily intranasal TAO application. One week after treatment, all 30 subjects were reswabbed; 16 (53.3%) showed evidence of decolonization on repeat culture.The rate of S aureus colonization of healthcare workers in our study is lower than published rates in industrialized nations. Intranasal application of TAO may be a viable option for eradication of nasal colonization by methicillin-susceptible S aureus in environments where mupirocin-resistant bacterial strains become more prevalent.
Related Compounds
Related Articles:
2015-11-01
[Acta Biochim. Biophys. Sin. (Shanghai) 47 , 932-7, (2015)]
2013-04-01
[Appl. Biochem. Biotechnol. 169(8) , 2263-72, (2013)]
A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.
2009-04-01
[PLoS Pathog. 5 , e1000392, (2009)]
Streptococcus pyogenes polymyxin B-resistant mutants display enhanced ExPortal integrity.
2014-07-01
[J. Bacteriol. 196(14) , 2563-77, (2014)]
2013-06-01
[Clin. Nephrol. 79(6) , 463-70, (2013)]